Surrozen Inc (NASDAQ:SRZN) — Market Cap & Net Worth
Market Cap & Net Worth: Surrozen Inc (SRZN)
Surrozen Inc (NASDAQ:SRZN) has a market capitalization of $269.94 Million ($269.94 Million) as of June 23, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #15417 globally and #3590 in its home market, demonstrating a 6.80% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Surrozen Inc's stock price $23.25 by its total outstanding shares 11610371 (11.61 Million). Review Surrozen Inc total liabilities to assess the company's total debt and financial obligations.
Surrozen Inc Market Cap History: 2021 to 2026
Surrozen Inc's market capitalization history from 2021 to 2026. Data shows change from $1.12 Billion to $269.94 Million (-29.18% CAGR).
Index Memberships
Surrozen Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.42 Trillion | 0.01% | #417 of 976 |
|
NASDAQ Composite
IXIC
|
$41.03 Trillion | 0.00% | #1494 of 3165 |
Weight: Surrozen Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Surrozen Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Surrozen Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
75.47x
Surrozen Inc's market cap is 75.47 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $101.36 Million | $12.50 Million | -$27.67 Million | 8.11x | N/A |
| 2023 | $109.14 Million | $12.50 Million | -$43.04 Million | 8.73x | N/A |
| 2024 | $166.61 Million | $10.65 Million | -$63.56 Million | 15.64x | N/A |
| 2025 | $262.39 Million | $3.48 Million | -$242.03 Million | 75.47x | N/A |
Competitor Companies of SRZN by Market Capitalization
Companies near Surrozen Inc in the global market cap rankings as of June 23, 2026.
Key companies related to Surrozen Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #220 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #445 globally with a market cap of $62.84 Billion USD.
- UCB SA (BR:UCB): Ranked #547 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #571 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #220 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $451.63 |
| #445 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $62.84 Billion | $609.94 |
| #547 | UCB SA | BR:UCB | $49.68 Billion | €249.70 |
| #571 | Argen-X | BR:ARGX | $47.14 Billion | €773.80 |
Surrozen Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, Surrozen Inc's market cap moved from $1.12 Billion to $ 269.94 Million, with a yearly change of -29.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $269.94 Million | +2.88% |
| 2025 | $262.39 Million | +57.49% |
| 2024 | $166.61 Million | +52.66% |
| 2023 | $109.14 Million | +7.67% |
| 2022 | $101.36 Million | -90.96% |
| 2021 | $1.12 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 22nd, 2026 the market cap of Surrozen Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $269.94 Million USD |
| MoneyControl | $269.94 Million USD |
| MarketWatch | $269.94 Million USD |
| marketcap.company | $269.94 Million USD |
| Reuters | $269.94 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Surrozen Inc
Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea, cornea, skin, pancreas, and central nervous system. The company develops SZN-814, … Read more